iShares Biotechnology ETF (IBB) Dividend Yield, History & Forecast

iShares Biotechnology ETF (IBB) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 0.21% ($0.42 per share annually (TTM)). The most recent ex-dividend date was September 15, 2026, with payment scheduled for September 18, 2026. market capitalization is approximately $10.02B. Review IBB dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

IBB fund composition

IBB holds 244 positions, with 47.9% of assets in its ten largest. It charges an expense ratio of 0.44%, and manages $10.45B.

Top 10 holdings

HoldingWeight
AMGNAMGEN INC8.55%
VRTXVERTEX PHARMACEUTICALS8.04%
GILDGILEAD SCIENCES7.33%
REGNREGENERON PHARMACEUTICALS5.85%
MRNAMODERNA3.94%
ARGXARGENX SE ADR3.76%
NTRANATERA3.08%
RVMDREVOLUTION MEDICINES2.81%
ALNYALNYLAM PHARMACEUTICALS2.30%
BIIBBIOGEN2.22%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about iShares Biotechnology ETF (IBB)

What is iShares Biotechnology ETF's dividend yield?
iShares Biotechnology ETF (IBB) pays a current trailing twelve-month dividend yield of 0.21%, which works out to $0.42 per share annually based on the most recent payout schedule.
When does iShares Biotechnology ETF pay distributions?
The most recent ex-dividend date was September 15, 2026. The next scheduled dividend payment date is September 18, 2026.
What does iShares Biotechnology ETF invest in?
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.